Talbert RL - Search Results

1

Principles of drug administration in renal insufficiency.

Lam YW, Banerji S, Hatfield C, Talbert RL. Lam YW, et al. Among authors: talbert rl. Clin Pharmacokinet. 1997 Jan;32(1):30-57. doi: 10.2165/00003088-199732010-00002. Clin Pharmacokinet. 1997. PMID: 9012555 Review.

2

Drug dosing in patients with renal insufficiency. A simplified approach.

Bakris GL, Talbert R. Bakris GL, et al. Postgrad Med. 1993 Dec;94(8):153-6, 159-60, 163-4. Postgrad Med. 1993. PMID: 8247992 Review.

3

Safety issues with statin therapy.

Talbert RL. Talbert RL. J Am Pharm Assoc (2003). 2006 Jul-Aug;46(4):479-88; quiz 488-90. doi: 10.1331/154434506778073637. J Am Pharm Assoc (2003). 2006. PMID: 16913392 Review.

4

Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections.

Frei CR, Miller ML, Lewis JS 2nd, Lawson KA, Peddaiahgari R, Talbert RL. Frei CR, et al. Among authors: talbert rl. Clin Ther. 2010 Nov;32(12):2024-9. doi: 10.1016/j.clinthera.2010.11.004. Clin Ther. 2010. PMID: 21118737

5

Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studies.

Talbert RL, Pieper JA, Ito MK; National Cholesterol Education Program. Talbert RL, et al. Am J Health Syst Pharm. 2003 Jul 1;60(13 Suppl 2):S22-4; quiz S25. doi: 10.1093/ajhp/60.suppl_2.S22. Am J Health Syst Pharm. 2003. PMID: 12901027 No abstract available.

6

Modification of high-density lipoprotein cholesterol in the management of cardiovascular risk.

Koeller J, Talbert RL. Koeller J, et al. Among authors: talbert rl. Pharmacotherapy. 2002 Oct;22(10):1266-77. doi: 10.1592/phco.22.15.1266.33475. Pharmacotherapy. 2002. PMID: 12389877 Review.

7

Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam.

Mahaguna V, Talbert RL, Peters JI, Adams S, Reynolds TD, Lam FY, Williams RO 3rd. Mahaguna V, et al. Among authors: talbert rl. Eur J Pharm Biopharm. 2003 Nov;56(3):461-8. doi: 10.1016/s0939-6411(03)00116-4. Eur J Pharm Biopharm. 2003. PMID: 14602191 Clinical Trial.

8

Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.

McConville JT, Overhoff KA, Sinswat P, Vaughn JM, Frei BL, Burgess DS, Talbert RL, Peters JI, Johnston KP, Williams RO 3rd. McConville JT, et al. Among authors: talbert rl. Pharm Res. 2006 May;23(5):901-11. doi: 10.1007/s11095-006-9904-6. Epub 2006 May 5. Pharm Res. 2006. PMID: 16715380

9

Single dose and multiple dose studies of itraconazole nanoparticles.

Vaughn JM, McConville JT, Burgess D, Peters JI, Johnston KP, Talbert RL, Williams RO 3rd. Vaughn JM, et al. Among authors: talbert rl. Eur J Pharm Biopharm. 2006 Jun;63(2):95-102. doi: 10.1016/j.ejpb.2006.01.006. Epub 2006 Mar 3. Eur J Pharm Biopharm. 2006. PMID: 16516450

10

Aspirin dosage and thromboxane synthesis in patients with vascular disease.

Hart RG, Leonard AD, Talbert RL, Pearce LA, Cornell E, Bovill E, Feinberg WM. Hart RG, et al. Among authors: talbert rl. Pharmacotherapy. 2003 May;23(5):579-84. doi: 10.1592/phco.23.5.579.32206. Pharmacotherapy. 2003. PMID: 12741431 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results